Gallerani M, Cicognani I, Ricci A, Martinelli L, Dall'Ara G, Ferrari R, Faggioli M
Emergency Department, St. Anna Hospital, USL 31 Ferrara, Italy.
Riv Eur Sci Med Farmacol. 1990 Jun;12(3):191-5.
In heterozygote beta-thalassemic subjects in a higher incidence of infectious diseases and of liver diseases with progression toward chronic hepatitis has been assessed. This predisposition has been suggested as being related to some immunological defects and to an altered immunological reactivity in thalassemia trait carriers. In order to evaluate whether there is a real deficiency of some humoral and cellular parameters in healthy heterozygote beta-thalassemic subjects, 128 symptom-free volunteers have been studied: 40 were heterozygote beta thalassemia carriers and 88 were normal subjects. In both groups there was no difference in: number and percentage of total lymphocytes, gamma globulins, immunoglobulins A and M, number and percentage of CD21, CD3, CD4, CD8, number of OKla1, CD4/CD8 rations and lymphocytes' ability to respond to phytohemagglutinin. The values of immunoglobulins G and percentages of OKla1 were found to be higher only in heterozygote beta thalassemic subjects; however, the number of CD2 in these subjects was lower. The result of the present study seems to indicate there is not significant difference between heterozygote beta thalassemic carriers and normal subjects in the more usual humoral and cellular immunological parameters.
对杂合子β地中海贫血患者中传染病发病率较高以及肝脏疾病进展为慢性肝炎的情况进行了评估。这种易感性被认为与某些免疫缺陷以及地中海贫血特征携带者免疫反应性改变有关。为了评估健康的杂合子β地中海贫血患者是否真的存在某些体液和细胞参数的缺乏,对128名无症状志愿者进行了研究:40名是杂合子β地中海贫血携带者,88名是正常受试者。两组在以下方面无差异:总淋巴细胞数量和百分比、γ球蛋白、免疫球蛋白A和M、CD21、CD3、CD4、CD8的数量和百分比、OKla1数量、CD4/CD8比值以及淋巴细胞对植物血凝素的反应能力。仅在杂合子β地中海贫血患者中发现免疫球蛋白G值和OKla1百分比更高;然而,这些患者的CD2数量更低。本研究结果似乎表明,杂合子β地中海贫血携带者与正常受试者在更常见的体液和细胞免疫参数方面无显著差异。